Xilio Therapeutics Inc (XLO)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -55.199 | -111.51 | -59.597 | -49.393 | -76.369 |
| Return on Equity (%) | 117.271 | 97.897 | -148.421 | -60.618 | -107.253 |
| Return on Invested Capital (%) | -82.057 | -233.985 | -77.568 | -59.382 | -111.358 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | -0.806 | 6.778 | 3.852 | 1.337 |
| Earnings Per Share | N/A | -8.424 | -2.771 | -3.217 | -2.774 |
| Cash Per Share | N/A | 2.935 | 7.239 | 4.39 | 1.623 |
| Working Capital Per Share | N/A | -0.239 | 6.935 | 3.769 | 1.168 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | -8.424 | -2.771 | -3.217 | -2.774 |
| EBITDA Per Share | N/A | -8.424 | -2.771 | -3.217 | -2.774 |
| Free Cash Flow Per Share | N/A | -8.253 | -2.785 | -3.211 | -2.822 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | 6.56M | 27.36M | 27.43M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | 27.43M | N/A | N/A | N/A | N/A | 34.47M | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 41.23M |
| Price to Earnings Ratio | -0.59 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 1.22 |
| Dividend Yield | - |
| Shares Outstanding | 43.96M |
| Average Volume (1 week) | 1.05M |
| Average Volume (1 Month) | 343.24k |
| 52 Week Change | 78.74% |
| 52 Week High | 1.93 |
| 52 Week Low | 0.49 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
